Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.
about
Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysisCan we prevent antimicrobial resistance by using antimicrobials better?Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-LactamasesActivities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.DNA, cell wall and general oxidative damage underlie the tellurite/cefotaxime synergistic effect in Escherichia coli.Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious DiseasesUse of xylitol to enhance the therapeutic efficacy of polymethylmethacrylate-based antibiotic therapy in treatment of chronic osteomyelitisIdentification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa.Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System.Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibioticsThe empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.Recycling antibiotics into GUMBOS: a new combination strategy to combat multi-drug-resistant bacteria.Impact of Combination Antibiogram and Related Education on Inpatient Fluoroquinolone Prescribing Patterns for Patients With Health Care-Associated Pneumonia.Antibacterial Derivatives of Ciprofloxacin to Inhibit Growth of Necrotizing Fasciitis Associated Penicillin Resistant Escherichia coli.Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.Novel Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro.Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens.Megalin contributes to kidney accumulation and nephrotoxicity of colistin.Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients.In Vitro Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa.[Strategies to avoid antibiotic resistance].
P2860
Q26783911-6F2E9CAE-B43E-473F-AC5B-E6853AF91FEFQ26829707-6132DC9D-27B0-456B-88C6-E6DC2DF04E72Q28249617-1A4182F5-9767-49D8-AA8E-6CD3A76CE226Q34922363-32A6B671-E9B5-4B34-AF59-1F645085201FQ35048486-96436401-D778-41A2-8EB2-2BC5DA78E045Q35975439-EFBA5AB4-B00C-4E85-8B0E-8C2827531F94Q35986250-D05699E2-10AF-429C-A358-C7BC3083223DQ36364129-EEF6A55B-1F6D-426F-88EF-5F624E7616DFQ36409828-37628FBD-8D44-4712-9583-ED14508AED44Q36933502-AA05C65B-EF03-4C14-93A4-B8D93FE9D418Q37680591-F91D5894-A578-45CE-8E86-642FCCDE1D7CQ38132301-5A4B54DF-27A7-4043-BB9B-88DE912D3D18Q38697988-0D0CA4E6-BB30-4B55-A00E-EA354D2657BCQ38888005-4EA65F67-5426-41CE-9186-32227C03F80CQ40090523-F1569A89-2495-4417-89AA-BB9592BDDEDCQ40335884-209EF0BE-F862-48CF-BD75-83AE723706F5Q40378879-0FC03465-7E87-4C64-954B-D5D9C906E444Q40626072-72136F1A-4C0A-43CB-B09F-225DB6FE9167Q40668393-6154524B-EE43-4302-9092-8E2EE330CC1DQ41564878-C7FE7735-0FF9-4518-871F-0B219AF1C1E9Q42110007-AA425E97-52E1-4299-8F90-4A8309BF1CF4Q44064611-1613D2CA-B655-4B26-A154-90A7193BC5DFQ47769606-FBAA5CA8-FAE0-45C3-B46A-6F619697FB20Q52885133-35E1BF32-6D23-4BD9-9E6C-37CBAFBD5049
P2860
Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Combination antibiotic therapy ...... fectious Diseases Pharmacists.
@en
Combination antibiotic therapy ...... fectious Diseases Pharmacists.
@nl
type
label
Combination antibiotic therapy ...... fectious Diseases Pharmacists.
@en
Combination antibiotic therapy ...... fectious Diseases Pharmacists.
@nl
prefLabel
Combination antibiotic therapy ...... fectious Diseases Pharmacists.
@en
Combination antibiotic therapy ...... fectious Diseases Pharmacists.
@nl
P2860
P356
P1433
P1476
Combination antibiotic therapy ...... fectious Diseases Pharmacists.
@en
P2093
Michael D Nailor
Natalie Boyd
P2860
P304
P356
10.1592/PHCO.31.11.1073
P407
P577
2011-11-01T00:00:00Z